ClearPoint Neuro, Inc. Quarterly Cost of Revenue in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
ClearPoint Neuro, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2017 to Q3 2024.
  • ClearPoint Neuro, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $3.28M, a 31.6% increase year-over-year.
  • ClearPoint Neuro, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $12.1M, a 28.9% increase year-over-year.
  • ClearPoint Neuro, Inc. annual Cost of Revenue for 2023 was $10.3M, a 47.3% increase from 2022.
  • ClearPoint Neuro, Inc. annual Cost of Revenue for 2022 was $7.02M, a 35.6% increase from 2021.
  • ClearPoint Neuro, Inc. annual Cost of Revenue for 2021 was $5.18M, a 39.6% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $12.1M $3.28M +$786K +31.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $11.3M $2.87M +$46K +1.63% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $11.2M $3.11M +$883K +39.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $10.3M $2.8M +$989K +54.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $9.35M $2.49M +$1.02M +69.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $8.33M $2.82M +$879K +45.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $7.45M $2.23M +$431K +23.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $7.02M $1.81M +$720K +66.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $6.3M $1.47M -$66K -4.31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.37M $1.95M +$806K +70.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $5.56M $1.8M +$384K +27.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $5.18M $1.09M +$16K +1.49% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $5.16M $1.53M +$630K +69.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $4.53M $1.14M +$337K +42% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $4.19M $1.42M +$484K +51.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $3.71M $1.07M +$29.8K +2.86% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $3.68M $903K -$80K -8.14% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.76M $802K -$228K -22.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $3.99M $932K +$45.5K +5.14% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $3.94M $1.04M +$354K +51.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 $3.59M $983K +$430K +77.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $3.16M $1.03M +$428K +71.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.73M $886K +$298K +50.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $2.43M $689K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $553K -$136K -19.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $602K -$196K -24.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $589K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 $689K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $798K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.